Authors: AAPRO MS WAGSTAFF J LATOUR C BARLEY VL BOSANQUET N CARMICHAEL J

Citation: Ms. Aapro et al., A FRAMEWORK FOR ASSESSING THERAPEUTIC INNOVATION, Anti-cancer drugs, 4, 1993, pp. 27-31

Authors: BLEEHEN NM GIRLING DJ MACHIN D STEPHENS RJ BARLEY VL BULLIMORE JA WHITE RJ BLEEHAN NM WILLIAMS MV BREDIN CP DAVIDSON AR WILLIAMS TJ ASH DV CLOSE HJ JOSLIN CA MUERS MF STONE J ASHFORD RF DISCHE S DUNPHY EP FERMONT DC GROSCH E MAHER EJ SAUNDERS MI ADAM RJ ALCOCK CJ BENSON MK HOPKIN JM LANE DJ HUNTER AM

Citation: Nm. Bleehen et al., A RANDOMIZED TRIAL OF 3 OR 6 COURSES OF ETOPOSIDE CYCLOPHOSPHAMIDE METHOTREXATE AND VINCRISTINE OR 6 COURSES OF ETOPOSIDE AND IFOSFAMIDE INSMALL-CELL LUNG-CANCER (SCLC) .1. SURVIVAL AND PROGNOSTIC FACTORS, British Journal of Cancer, 68(6), 1993, pp. 1150-1156

Authors: BLEEHEN NM GIRLING DJ MACHIN D STEPHENS RJ HARTLEY JPR HODSON NJ TURTON CW BARLEY VL BULLIMORE JA WHITE RJ BLEEHEN NM WILLIAMS MV BREDIN CP DAVIDSON AR WILLIAMS TJ ASH DV CLOSE HJ JOSLIN CA MUERS MF STONE J ASHFORD RF DISCHE S DUNPHY EP FERMONT DC GROSCH E MAHER EJ SAUNDERS MI ADAM RJ ALCOCK CJ BENSON MK HOPKIN JM LANE DJ HUNTER AM

Citation: Nm. Bleehen et al., A RANDOMIZED TRIAL OF 3 OR 6 COURSES OF ETOPOSIDE CYCLOPHOSPHAMIDE METHOTREXATE AND VINCRISTINE OR 6 COURSES OF ETOPOSIDE AND IFOSFAMIDE INSMALL-CELL LUNG-CANCER (SCLC) .2. QUALITY-OF-LIFE, British Journal of Cancer, 68(6), 1993, pp. 1157-1166

Authors: WILLIAMS CJ BARLEY VL BLACKLEDGE GR ROWLAND CG TYRRELL CJ

Citation: Cj. Williams et al., MULTICENTER CROSS-OVER STUDY OF AMINOGLUTETHIMIDE AND TRILOSTANE IN ADVANCED POSTMENOPAUSAL BREAST-CANCER, British Journal of Cancer, 68(6), 1993, pp. 1210-1215